Since a clear proof for the binding ofthe albumin-bound radioligand to SST2 is challenging toprovide, we sought to quantitatively describe the principal effectsof albumin binding of radioligands in the blood circulation on thetime course of excretion and tumor uptake using a dedicated three-compartmentmodel. The gene discussed is ALB; the disease is neoplasm.